Publications found:
282,232
Sort by:
Global Iclusig Market Research Report 2024, Forecast to 2032
US$ 3,400.00
Report Overview Iclusig is an oral drug developed by ARIAD Pharmaceuticalsfor the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome–positive (Ph+) acute lymphoblastic leukemia(AL...
October 2024
100 pages
Global Idhifa Market Research Report 2024, Forecast to 2032
US$ 3,400.00
Report Overview Idhifa is a drug used to treat relapsed or refractory acute myeloid leukemia in people with specific mutations of the isocitrate dehydrogenase 2 (IDH2) gene, determined by an FDA-appro...
October 2024
100 pages
Global Imfinzi Market Research Report 2024, Forecast to 2032
US$ 3,400.00
Report Overview IMFINZI® (durvalumab) is an immunotherapy used to treat patients with urothelial carcinoma, a type of bladder cancer The global Imfinzi market size was estimated at USD 2784 million in...
October 2024
100 pages